RSS   Newsletter   Contact   Advertise with us

Christopher Pechock joins Myos board of directors

Staff writer | Cedar Knolls, NJ, USA | February 27, 2014
MyosFebruary 27, 2014, Cedar Knolls, NJ, USA - Myos Corporation, a biotherapeutics and bionutrition company, announced that it has appointed Christopher Pechock to its board of directors.
Mr. Pechock brings to MYOS more than 25 years of Wall Street experience as an investment banker, buy-side and sell-side analyst, and private equity professional. Mr. Pechock currently is a Partner and Chairman of the Investment Committee of Matlin Patterson Global Advisers. Prior to joining MatlinPatterson at inception in July 2002, Mr. Pechock was a member of Credit Suisse's Global Distressed Securities Group (1999-2002).

Prior to joining Credit Suisse, Mr. Pechock was a Portfolio Manager and Research Analyst in distressed securities at Turnberry Capital Management, L.P. (1997-1999), a Portfolio Manager in distressed securities and special situations at Eos Partners, L.P. (1996-1997), a Vice President and high yield analyst at PaineWebber Inc. (1993-1996) and an analyst in corporate finance and risk arbitrage at Wertheim Schroder & Co., Incorporated (1987-1991).

He serves on the Boards of Directors of Oceanus LLC and Gleacher & Company. He previously served on various other Boards, including Renewable Biofuels, Comsys IT, Compass Aerospace, Goss International, Huntsman Corporation, XL Health Corporation, Leprechaun Holding Company, FXI Holdings, Icon Health and Fitness, and Spincycle, Inc.

Mr. Pechock holds an MBA from the Columbia University Graduate School of Business (1993) and a BA in Economics from the University of Pennsylvania (1987).


 LATEST MOVES FROM  


MORE INSIDE POST